In six sheep anaesthetised with ketamine blood was sampled from the jugular and femoral veins and the femoral artery at frequent intervals for 12 minutes following the intravenous administration of 5 or 10 mg/kg sodium thiopentone. Samples were also taken from cubital veins and radial arteries of five patients who received 5 mg/kg thiopentone. The plasma concentration of thiopentone was determined by an HPLC assay. The time course of plasma concentration of thiopentone showed considerable variation according to sampling site as well as variation between individuals. Such sampling site-dependent variation may result in the appearance of acute tolerance.
sheep.
Pharmacokinetic studies on thiopentone usually involve an examination of the time course of plasma concentrations from a peripheral vein. However, it is well recognised that the brief anaesthetic action of thiopentone is largely due to redistribution to tissues such as skeletal muscle. The venous concentrations of thiopentone must reflect the concentrations in the tissue drained by the vein which is sampled. This may not correspond with concentrations at its site of action within the brain. Therefore, during an on-going study o(the kinetics of thiopentone, two series of experiments were undertaken to define the role of the sampling site in relation to the kinetic profile obtained during the distributional phase. In previous studies with thiopentone, it has generally been assumed that either the plasma compartment is homogeneous or that equilibration occurs within the compartrrtent rapidly.l,2 This assumption previously has not been tested.
METHODS
Six healthy fasted female sheep weighing from 21 to 44 kg were anaesthetised with ketamine 30 mg/kg intramuscularly. The jugular vein (this is superficial in sheep) and a foreleg vein were cannulated percutaneously. The femoral artery and vein were cannulated by cut-down. Thiopentone 5 or 10 mg/kg as a 2,5fl70 solution was injected into the foreleg vein and samples taken at the other three sites at frequent intervals for 12 minutes into heparinised syringes.
In five patients who were about to undergo major surgery, with continuous monitoring of arterial pressure, informed consent was obtained. Following injection of thiopentone 5 mg/kg over 30 seconds, blood was sampled from an antecubital vein and the radial artery at frequent intervals for 12 minutes. Further data collection from human subjects is proceeding and the full report will be the subject of a separate communication.
The plasma of the blood samples was separated off and frozen until assay.
Thiopentone concentrations were determined after extraction by high-performance liquid chromatography. Aliquots of plasma (0.25-0.5 ml) or aqueous standards were adjusted to 1.0 ml with distilled water. The aqueous phase was acidified with saturated potassium dihydrogen phosphate (0.6 ml) and extracted with ether (4 ml), containing the internal standard, thioamylobarbitone (8 JAg). The extract was evaporated, reconstituted in methanol (0.1 ml) and clarified by centrifugation. Aliquots of the final extract (5-10 JAI) were assayed by highperformance liquid chromatography using the solvent mixture methanol, water, actonitrile (60, 37, 3) at a flow rate of 0.7 mllmin. The column was 5 micron Ultras ph ere ODS (ALTEX: 4.6 mm O.D. x 25 cm). HPLC equipment included a model U6 K injector, model 6000 A pump and a model 440 UV detector (Waters Associates) set at 280 nm. Standard curves were constructed after measurement of peak height ratios. The recovery from aqueous solutions was not significantly different from the recovery from plasma.
RESULTS
In all six sheep, the pattern of arterial plasma concentrations was very similar. Concentrations fell rapidly over the first two minutes with a more gradual decrease over the next ten minutes, both in an exponential manner ( Figure 1 ). The concentrations in the jugular vein followed the arterial concentrations closely after 1.5 minutes. In all sheep the jugular concentration remained higher than the concentration of thiopentone in the femoral vein ( Table 1) . The time course of concentrations in the femoral vein was markedly different from that in the artery and jugular vein. In five of the six sheep, the plasma concentrations rose rapidly over the first minute after the end of the inj ection. Thereafter, the pattern of concentrations was variable. It tended to plateau in about four or five minutes; in three of the sheep this concentration was then The decline in plasma concentrations in the sheep was often not smooth; the curves being disturbed by random, minor fluctuations in concentrations (Figures 2a and 2b) . Because of the high accuracy and reproducibility of the assay, it is considered that these fluctuations are real and not due to analytical error. In the five patients the results were somewhat different. The arterial concentrations still exhibited a rapid and slow decline phase (Figures 3a and 3b ). The pattern of concentrations in the antecubital vein was not as consistent as in the femoral vein of the sheep. In three of the five patients, the concentration in the peripheral vein showed an· arterial-like pattern albeit at a lower concentration, while in two patients the time course of plasma concentrations resembled that in the femoral vein of the sheep. In these two patients the plasma concentrations in the antecubital vein rose quickly for 1-1 Yz minutes with little change thereafter. There were again significant fluctuations in the time course of the concentrations of thiopentone in the plasma from both sampling sites. 
DISCUSSION
A number of features emerge from the data obtained in these preliminary studies. The results from peripheral venous blood (femoral in sheep, antecubital in patients) can show different behaviour from arterial blood. As stated above, the rise in concentration is slower than in either arterial or jugular blood as is the decay. This is of considerable importance. It is reasonable to postulate that tissue concentration in a well-per fused organ, such as the brain, is close to that of the plasma perfusing it (allowing for a suitable partition coefficient). It is also probable that the effluent plasma concentration reflects tissue concentration to a significant extent. If this is accepted, then conclusions based upon blood samples from peripheral sites must be subject to re-evaluation, noting the differences in plasma concentrations between the sites. Even after four minutes or more considerable concentration differences existed between peripheral venous (antecubital or femoral) samples and arterial blood. Where concentration-effect relationships are to be considered these differences must be taken into account.
For example, Toner et al. 2 observed that the plasma concentrations of thiopentone on recovery from anaesthesia increased with increasing dosage. However, blood samples were taken from an antecubital vein and the correlation between dosage and waking plasma concentrations may be due, at least in part, to sampling site. The results of the present studies show the difference between the concentrations of thiopentone in assays on jugular vein and peripheral vein samples decreases with increasing time after dosage. Larger doses must produce a longer duration of action and, consequently, a decreased difference between concentrations in an artery and a peripheral vein on waking. Thus, even if the patients wake at constant plasma concentration, as judged from jugular or arterial samples, the concentration of thiopentone in a peripheral sample taken at that time must rise with increasing induction dose. Thus the appearance of acute tolerance may well be influenced by the sampling site.
